Breaking News on Global Pharmaceutical Technology & Manufacturing

Asia-Pacfic focus

17-Mar-2003

Related topics: Regulations in emerging markets, Regulatory & Safety

Singapore is the location for the first 'Drug Discovery Technology' event organised by IBC Life Sciences in the Asia-Pacific region.

Entitled 'Biomedical Research Applications in Drug Discovery Technology,' the show is aiming to tap into the strong growth of biomedical sciences in Asia-Pacific and has been designed to foster Pan-Asian scientific exchange among academic, government and industry research groups.

 

The event aims to provide a forum for biomedical companies from the US, Europe and Asia-Pacific to discuss partnerships, contract research opportunities, licensing arrangements and strategic alliances.

 

The Scientific Advisory Board includes Nigel Beeley, from Arena Pharmaceuticals, US, Kelvin Lam at Pfizer, Edison Liu, the executive director of the Genome Institute of Singapore, and Lorenz Mayr from Novartis Pharma.

 

The preliminary agenda includes two American Chemical Society short courses on organic chemistry and pharmacology, followed by a variety of partnering/business sessions.

 

The event will take place from 3-5 November 2003, at the Shangri-La Hotel in Singapore.

 

Copyright - Unless otherwise stated all contents of this web site are © 2012 - William Reed Business Media SAS - All Rights Reserved - For permission to reproduce any contents of this web site, please email our Syndication department copyright@wrbm.com - Full details for the use of materials on this site can be found in the Terms & Conditions

© 2012 - William Reed Business Media SAS - All rights reserved.